Atlas Trials

A Study to Compare the Pharmacokinetics and Safety Between BR9004 and BR9004-1 in Healthy Male Volunteers

Clinical trial NCT04889651 · COMPLETED

Trial details

NCT number
NCT04889651
Sponsor
Boryung Pharmaceutical Co., Ltd
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2021-04-15
Primary completion
2021-06-08
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.